Furthermore, next‐generation sequencing revealed that most patients with tumor reduction expressed medium or high levels of VEGFR2 and PDGFRβ mRNA, although there was no significant difference in their expression in biopsy tissues (Figure 4E,F). Here, PDGFRB is linked to neoplasm.